Lymphoma News & Leukemia News & Myeloma News from Medical News Today

Lymphoma / Leukemia / Myeloma News

Useful Links

Video Library

Lymphoma / Leukemia / Myeloma News

The latest Lymphoma News & Leukemia News & Myeloma News articles published daily. Includes news on hematological malignancies (blood and lymphatic cancers), Hodgkin's Disease, Epstein-Barr Virus and more.

Add this Lymphoma rss news feed to your rss reader:

Lymphoma / Leukemia / Myeloma News Articles Archive - Page 20

25 January 2007

Cephalon Comments On Study Of Its Leukemia Treatment Led By National Cancer Institute Cooperative Group

23 January 2007

Ortho Biotech Seeks FDA Approval For DOXIL(R) In Combination With VELCADE(R) To Treat Relapsed/Refractory Multiple Myeloma

22 January 2007

Researchers Develop New Strategy For The Treatment Of CML

Allergy Not Associated With Development Of Non-Hodgkin Lymphoma

19 January 2007

IPP-SHR - Relocation For Cancer Treatment Major Stress For Patients

18 January 2007

Researchers Develop New Method For Fighting Leukemia

17 January 2007

BioCryst Initiates Pivotal Fodosine(TM) Phase IIb Clinical Trial In Patients With Relapsed/Refractory T-Lymphoblastic Leukemia/Lymphoma

15 January 2007

Role For Proteomics In Identifying Hematologic Malignancies

10 January 2007

Dartmouth Researchers Find That Arsenic Triggers Unique Mechanism In Rare Leukemia

Curing Kids' Cancer Announces 2006 Pediatric Cancer Research Grants

09 January 2007

Interim Safety Analysis Supports Continuation Of Allos Therapeutics' Pivotal Phase 2 Trial Of Its Novel Antifolate PDX For Peripheral T-cell Lymphoma

05 January 2007

BCL2 Reins In BIM, Preventing Leukemic Cell Death

Arsenic Triggers Unique Mechanism In Rare Leukemia

04 January 2007

Cancerbackup Launches Comic To Help Children With Cancer, UK

03 January 2007

New Treatment Hope For Systemic Sclerosis

02 January 2007

The Multiple Myeloma Research Consortium (MMRC) And Keryx Biopharmaceuticals Commence Study For The Treatment Of Multiple Myeloma

Phase I/II Data Support Continued Development Of Biogen Idec's Novel Anti-Cd23 Antibody For Chronic Lymphocytic Leukemia

31 December 2006

Model Predicts Risk Of Leukemia Induced By Radiation Therapy

28 December 2006

Herceptin Plus Chemotherapy Significantly Increases Disease-Free Survival In Breast Cancer

27 December 2006

MabThera(REG) Helps Patients With Lymphoma Stay Symptom Free And Live Longer

26 December 2006

Pivotal Submission Data Shows Tasigna(R) Achieved Impressive Response Rates In Chronic Myeloid Leukemia Patients No Longer Helped By Gleevec(R)

Avalon's AVN944 Inhibits IMPDH And Induces Apoptosis-Related Biomarkers In Patients With Hematological Cancers

New Data Validate Vidaza(R) Response Rates In MDS And Report Results In AML

Pharmacyclics Announces Preclinical Data Publication Indicating Potential Use Of Its Novel Selective B-Cell Tyrosine Kinase Inhibitor Compounds

25 December 2006

"Bank On A Cure" Researchers Identify Pathways Mediating Myeloma Treatment Side Effects

CHOP Plus Zevalin (REG) Therapy Shows Efficacy In Elderly Patients With Most Common Type Of Aggressive Non-Hodgkin's Lymphoma

'Impressive' Complete Remission And 'Survival Data In Relapsed Indolent NHL Patients Identifies New Potential Registration Trial For Pixantrone

GPC Biotech Presents Preliminary Clinical Data On Anticancer Monoclonal Antibody 1D09C3 At ASH

Results Of Clinical Trial Program Suggest Fodosine(TM) Demonstrates Clinical Activity In Certain Types Of Leukemia And Lymphoma

24 December 2006

Children With Leukemia Are Living Longer, U Of MN Study Finds

Low Doses Of Humanized Anti-Cd20 Antibody Reported Active In Non-Hodgkin's Lymphoma

Genmab Initiates HuMax-CD20 Front Line CLL Study

23 December 2006

Tumour 'weather Forecast' Gives New Insights In Cancer

22 December 2006

Merck And Vertex Announce Start Of Pivotal Phase 2 Clinical Trial For Investigational Aurora Kinase Inhibitor MK-0457 (VX-680)

21 December 2006

Pair Of MicroRNA Molecules Controls Major Oncogene In Most Common Leukemia

18 December 2006

Spelling Out Cancer On The Nanoscale

17 December 2006

Lenalidomide Enhances Effects Of Monoclonal Antibodies In B-Cell Lymphoma

16 December 2006

Mayo Clinic -- Collaborating To Move Treatment Research Forward

Drug Combination Slows Progression Of Treatment Resistant Bone Marrow Cancer

MabThera First-line Treatment Helps Patients With Indolent Lymphoma Live Longer

15 December 2006

Drug Combination Proves Effective Against Myeloma In Phase I Trial

M. D. Anderson Reports First Drug Activity In T315I-Positive CML, ALL And JAK-2-Positive MPD

Working On The Tough Cases: Mayo Clinic Cancer Center

AVN944 Inhibits IMPDH & Induces Apoptosis-related Biomarkers In Patients With Hematologic Cancers

CuraGen And TopoTarget Announce Expansion Of Belinostat (PXD101) Clinical Trial In Cutaneous T-cell Lymphoma (CTCL)

14 December 2006

Mayo Clinic Cancer Center Collaborating To Find New Tools To Fight Leukemia

Mayo Clinic Cancer Center -- Individualizing Treatment For Multiple Myeloma Patients

Five-year Study By OHSU Cancer Institute Shows Gleevec's Excellent Survival Rate

13 December 2006

Studies At Cancer Conference Show New Therapies Changing Outlook For Blood Cancer Patients

ZymoGenetics Presents Results From Two Atacicept Phase 1b Clinical Trials In B-Cell Cancer

EntreMed Presents Data On The Combination Of Panzem(R) And Velcade(R) In Multiple Myeloma

CuraGen And TopoTarget Announce Presentation Of Updated PXD101 Phase II Multiple Myeloma Results At ASH

12 December 2006

Genmab Announces Additional Positive Results In HuMax-CD20 CLL Phase I/II Study

The Comprehensive Cancer Center At Our Lady Of Mercy Medical Center Reports Promising Results Using REVLIMID In Non-Hodgkin's Lymphoma Patients

Chronic Lymphocytic Leukemia Patients Respond To Lenalidomide

Positive Results From Combination Trials Build On VELCADE(R) (Bortezomib) For Injection Proven Single-Agent Strength In Relapsed Multiple Myeloma

Impressive Activity Of Allos Therapeutics' Novel Antifolate PDX In Patients With Peripheral T-Cell Lymphoma

Final Data From Phase III Study Show Single-Agent Alemtuzumab (Campath(R), MabCampath(R)) Superior To Chlorambucil For Patients With Untreated B-CLL

Interim Analysis Finds DOXIL(R)/VELCADE(R) Combination Significantly Prolongs Time To Progression In Previously Treated Multiple Myeloma Patients

Data From Phase III Comparative Study Show Campath(R) Superior To Chlorambucil As A First-line Therapy In B-CLL

Go To News Page:
[First Page] [Prev] 7 8 9 10 11 12 13 14 15 16 17 18 19 [20] 21 22 23 24 25 26 [Next] [Last Page]

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Back to front page

List of All Medical Articles